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Abstract
Previously we reported the identiﬁcation of a homozygous COL27A1 (c.2089G>C; p.Gly697Arg) missense variant and
proposed it as a founder allele in Puerto Rico segregating with Steel syndrome (STLS, MIM #615155); a rare
osteochondrodysplasia characterized by short stature, congenital bilateral hip dysplasia, carpal coalitions, and scoliosis. We
now report segregation of this variant in ﬁve probands from the initial clinical report deﬁning the syndrome and an additional
family of Puerto Rican descent with multiple affected adult individuals. We modeled the orthologous variant in murine
Col27a1 and found it recapitulates some of the major Steel syndrome associated skeletal features including reduced body
length, scoliosis, and a more rounded skull shape. Characterization of the in vivo murine model shows abnormal collagen
deposition in the extracellular matrix and disorganization of the proliferative zone of the growth plate. We report additional
COL27A1 pathogenic variant alleles identiﬁed in unrelated consanguineous Turkish kindreds suggesting Clan Genomics and
identity-by-descent homozygosity contributing to disease in this population. The hypothesis that carrier states for this
autosomal recessive osteochondrodysplasia may contribute to common complex traits is further explored in a large clinical
population cohort. Our ﬁndings augment our understanding of COL27A1 biology and its role in skeletal development; and
expand the functional allelic architecture in this gene underlying both rare and common disease phenotypes.

Introduction
Steel et al. clinically described 23 patients with a novel
orthopedic syndrome characterized by congenital bilateral hip
and radial head dislocation, short stature, carpal coalitions,
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scoliosis, foot abnormalities, and mildly dysmorphic features
[1, 2] [Steel Syndrome, STLS, MIM #615155]. Steel had
initially observed this phenotypic presentation in seven
patients from Puerto Rico in 1966 and reported his observations in 1973 as “The Puerto Rican syndrome” at an
orthopedic surgery conference [1, 3]. Clinical and genetic
evaluation of patients with STLS pointed to a distinct genetic
syndrome different from other well-characterized skeletal
dysplasias and connective tissue disorders. Targeted approaches evaluating genes associated with achondroplasia, Larsen
syndrome, and Ehlers–Danlos syndrome were undertaken but
unsuccessful at identifying a common molecular etiology for
the characteristic features of STLS [2].
In 2015, we reported a single family of Puerto Rican
origin with two affected siblings with a clinical diagnosis of
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STLS presenting with bilateral congenital hip dysplasia,
scoliosis, short stature, under-ossiﬁcation of femoral heads,
bilateral capitate and hamate bone coalitions, bilateral ﬁfth
ﬁnger clinodactyly, midface hypoplasia, and pes planus.
Exome sequencing (ES) of the two affected siblings
identiﬁed a shared homozygous rare missense variant
(c.2089G>C; p.Gly697Arg) in COL27A1, resulting in an
amino acid substitution in the collagen type XXVII alpha 1
protein [4]. This variant had been reported before in
population databases, but never in the homozygous state.
Moreover, it did not appear to have any disease associated
phenotypic consequences in young adult heterozygous
carriers. We suggested this variant to be a founder allele in
individuals of Puerto Rican descent segregating within a
common haplotype [4].
Subsequent studies in large cohorts including multiethnic
populations have identiﬁed the p.Gly697Arg variant in
additional individuals, albeit at very low frequency. However, this allele is enriched, as hypothesized, primarily in
individuals of Puerto Rican descent but also observed
in other populations from the Caribbean, including the
Dominican Republic and the island of St. Thomas, potentially due to migration within the region after the putative
founder mutation event. It has been estimated that the carrier frequency for the COL27A1 c.2089G>C (p.Gly697Arg)
variant in Puerto Ricans is 1:51, that the mutation likely
arose in a Native American haplotype background and that
it drifted in the Puerto Rican population due to a strong
population bottleneck about 9–14 generations ago [5],
consistent with the demographic history of the Caribbean
and the European colonization of the region [6].
Since our initial report, additional cases have been
published linking novel rare recessive alleles in COL27A1
with osteochondrodysplastic phenotypes, mainly in consanguineous pedigrees [7–11]. Patients presented with
clinical ﬁndings overlapping those of the reported Puerto
Rican patients with STLS, but also with additional features
not previously recognized in STLS, namely congenital
hearing loss and speech delay [7–11]. We now report on the
biology of this disease through an in vivo mouse model of
the most common disease-causing allele and the worldwide
allelic architecture in clinical populations. Our data support
a Clan Genomics hypothesis [12] for derivation of pathogenic variant alleles.

Subjects and methods
Samples
All patients included in this study were consented under an
Institutional Review Board (IRB)-approved research protocol
(H-29697) of Baylor College of Medicine. DiscovEHR
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participants are a subset of the Geisinger MyCode® Community Health Initiative. The MyCode® Community Health
Initiative is a repository of blood, serum, and DNA samples
from Geisinger patients that have been consented to participate in research and donate samples for broad research use,
including genomic analyses that can be linked to de-identiﬁed
electronic health record (EHR) information. DiscovEHR
participants were consented in accordance with the Geisinger
Institutional Review Board approved protocol, Study number
2006–0258.

Targeted mutation testing of Steel syndrome
c.2089G>C (p.Gly697Arg) variant
We obtained DNA from the affected probands, siblings, and
unaffected parents and relatives for six of the originally
reported Steel syndrome families [1, 2]. Targeted genotyping
of the speciﬁc STLS variant [hg19 chr9:g.116958257G>C;
COL27A1:c.2089G>C; p.Gly697Arg] was performed on
all available individuals through sequence-speciﬁc PCR
ampliﬁcation and Sanger dideoxynucleotide sequencing.
Genotyping was performed masked to affectation status and
then matched to the available phenotype information. Similarly, we performed variant genotyping in an additional two
patients of Puerto Rican ancestry that were referred to us for
genomic studies through the Baylor-Hopkins Center for
Mendelian Genomics (BHCMG) with a clinical presentation
of STLS. A third family of Turkish ancestry where the
proband (BAB10793) was given a clinical diagnosis of STLS
was molecularly tested by Sanger sequencing of the entire
COL27A1 gene.

Exome sequencing and analysis
We performed ES and analysis through the BHCMG
initiative as previously described [13] in two probands with
unspeciﬁed skeletal dysplasia from two separate consanguineous Turkish families. In addition, we performed ES
in three affected adult siblings from a single family of
Puerto Rican ancestry from New York (HOU2809) and
with a clinical presentation of STLS in which the proband
was shown to be positive for the STLS variant by targeted
genotyping. We validated and segregated the candidate
variants of interest in these three families through PCR
ampliﬁcation followed by Sanger sequencing. All identiﬁed
novel COL27A1 variants reported here have been deposited
under accession ID SCV001190084 for public access
through ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/).
In addition, genomic and phenotypic data for all subjects
who have provided informed consent for data sharing
in controlled-access databases have been submitted to the
database of genotypes and phenotypes under accession
phs000711.v5.
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Sample preparation, ES, and sequence data production
for the DiscovEHR participants were performed at the
Regeneron Genetics Center as previously described [14].
BafCalculator was used to calculate a B-allele frequency
at each variant position from ES data [15]. NMDEscPredictor was used to assess potential susceptibility to nonsense mediated decay (NMD) [16].

Identity-by-decent (IBD) segment detection
We used KING 2.1.5 [17] with the –ibdseg command to
identify all pairwise IBD segments between carriers of the
hg19 chr9:g.116958257G>C variant using Illumina GSA
genotyping array data for each sample. IBD segments on
chromosome 9 were extracted from the KING results ﬁle
and were visually tiled across the chromosome to illustrate
the pileup of shared IBD that spanned the region containing
the variant of interest. The shared IBD haplotype was
deﬁned as the minimum region of overlap across all variant
carriers that have not been broken by recombination events.

Animal care ethics statement and maintenance
All mice used in this study were housed under a speciﬁc
pathogen free environment at the Regeneron Pharmaceuticals
Inc. animal research facility. Autoclaved water and sterile
mouse chow were provided ad libitum. All experimental
protocols, anesthesia, imaging procedures, and tissue sampling procedures performed in this study were approved by
the Regeneron Pharmaceuticals Inc. Institutional Animal Care
and Use Committee.

Generation of Col27a1 mutant mice
To model the human p.Gly697Arg variant, a guanine-tocytidine mutation, resulting in a p.Gly682Arg substitution
(orthologous to the human variant), was introduced in the
highly conserved triple-helical domain of the murine
Col27a1 gene. The mutation was introduced in exon 7 of 61
(exonID: ENSMUSE00001215121 [build GRCm38]) of the
mouse gene using standard protocols for CRISPR/Cas9
gene editing and the VelociGene© method [18, 19]. The
ﬁnal targeting vector was electroporated into C57BL/6N
mouse embryonic stem cells, and selected via hygromycin
resistance in the self-deleting cassette inserted in the
downstream intron. Additional details on the targeting
vector design and allele modiﬁcation protocol can be found
in Supplementary Methods. Mice carrying the introduced
mutation were conﬁrmed by Sanger dideoxynucleotide
sequencing genotyping. Targeted, cassette-deleted knockin
(KI) mice were bred to obtain desired genotypes. Homozygous and heterozygous KI mice cohorts derived from F1
breeding were generated for phenotypic evaluation.
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Mouse embryo phenotyping
X-ray µCT using iodine as a soft tissue enhancing contrast
agent was performed as previously described [20]. Brieﬂy,
embryonic day 18.5 (E18.5) embryos were dissected and
ﬁxed using 4F1G ﬁxative (4% PFA, 1% Glutaraldehyde in
PBS) for 24 h. Embryos were skinned and then placed in a
1% iodine potassium iodide (IKI) solution for 24 h. Subsequently, embryos were embedded in agarose and imaged
with an X-ray micro-computed tomography device (Zeiss
VERSA XRM500). The data were acquired with an X-ray
tube voltage of 100 kV, a current of 90 mA, an exposure
time of 1300 ms, with 1025 views, and using the ×0.39
objective lens. Data were reconstructed at a pixel size of
20.6 µm using the XRadia software (XMReconstructor
Cone Beam v10) and visualized using Amira 5.6.

Growth and skeletal phenotyping
Mice were monitored for growth kinetics by recording weight
at speciﬁed time points and gross skeletal phenotyping was
performed by biweekly imaging with in vivo µCT performed
as previously described [21]. Brieﬂy, whole body µCT imaging was performed using a high speed in vivo μCT scanner
(Quantum FX, PerkinElmer, Hopkinton, MA, USA). The
X-ray source was set to a current of 88 μA, voltage of 90 kV.
The CT imaging was visualized via 3D Viewer, existing
software within the Quantum FX system. The ﬁeld of view
was 60, and voxel size was 240 μm. Mice were kept under
anesthesia during scanning. Speciﬁcally, anesthesia was
induced by keeping the mice under 2.5–3% Isoﬂurane with
1.5 l/min oxygen ﬂow for 2–3 min and then positioned on the
scan platform. Constant delivery of isoﬂurane was achieved
via a nose cone connected to the scan platform. Following the
scanning process, mice were recovered under a heating lamp
and returned to their cages.
Following scanning, image processing steps were undertaken. Bone mineral density (BMD) and bone mineral content
(BMC) were calculated from the µCT scanned image data
using Analyze software package (AnalyzeDirect, Overland
Park, KS, USA). BMC was calculated as BMD × Bone
volume (mm3) × 1000. Volex gray intensities of the reconstructed images were transformed to linear Hounsﬁeld units or
linear attenuation coefﬁcient, the scale is based on the data
from images of the calibrating phantom, where air is −1000
HU and water 0 HU. Image segmentation was performed
semiautomatically using the Volume Edit tools within the
Analyze software package (AnalyzeDirect, Overland Park,
KS, USA). Brieﬂy, segmentation masks (object maps) were
created using a combination of semiautomatic and manual
techniques (object extraction, region growing, and thresholding tools). These segmentation results were then manually
modiﬁed if necessary and quantiﬁed using the ROI tools.
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Histological analyses of mouse long bones
Post-natal day 1 (P1) long bone samples were ﬁxed in 4%
PFA at 4 °C for 16 h. Following ﬁxation, samples were
thoroughly washed with cold PBS multiple times and parafﬁn embedded without decalciﬁcation. Samples were sectioned at 3 µm until the plane of sectioning revealed the
growth plate. Sections were then subjected to hematoxylin
and eosin (H&E), Safranin-O or von Kossa staining
according to standard protocols. Stained sections were
imaged using Aperio Scanscope at ×40 magniﬁcation. For
immunohistochemistry, all tibial samples underwent hyaluronidase digest (0.25% in Tris-buffered saline (TBS)) at
37 °C for 1 h. Samples were rinsed with TBS with 0.1%
Triton-X. Subsequently, samples were incubated in blocking buffer, (10% goat serum, 3% bovine serum albumin
(BSA) in TBS) for 1 h at room temperature. For Collagen II
staining, sections were incubated overnight at 4 °C in a
humidiﬁed chamber with primary antibody (II-II6B3,
DSHB, 1:100 dilution). Sections were rinsed with TBS and
incubated in goat anti mouse AF488 (A-11001, Invitrogen,
1:400 dilution) for 1 h at room temperature in 3% BSA in
TBS. For Collagen X staining, sections were incubated
overnight at 4 °C in a humidiﬁed chamber with primary
antibody (X-AC9, DSHB, 1:100 dilution) diluted in 3%
BSA in TBS. Sections were rinsed in TBS and incubated in
goat anti mouse secondary AF594 (A-11005, Invitrogen,
1:400 dilution) for 1 h at room temperature in 3% BSA in
TBS. Slides were rinsed and mounted with FluoroGel
(17983–100, Electron Microscopy Sciences). Stained tissues were imaged using a Zeiss Axio Observer microscope.

Results
Conﬁrmation of the COL27A1 c.2089G>C
(p.Gly697Arg) variant in additional Steel
syndrome patients
To further investigate our founder allele hypothesis [4] that
homozygosity for the c.2089G>C (p.Gly697Arg) variant in
COL27A1 is the molecular culprit for the clinically characterized Steel syndrome, we obtained samples from six of
the originally reported and later on further clinically characterized patients with the deﬁning syndrome STLS [1, 2]
and their available family members. All of these families are
from the island of Puerto Rico and reportedly nonconsanguineous. We genotyped our previously reported
STLS associated variant (hg19 chr9:g.116958257G>C;
COL27A1:c.2089G>C; p.Gly697Arg) (Fig. 1a) in the
COL27A1 gene in all family members. Indeed, and in
accordance with Mendelian expectations for an autosomal
recessive (AR) disease trait, co-segregation of the
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c.2089G>C (p.Gly697Arg) variant with disease affectation
status was observed in ﬁve of the six families genotyped
(Supplementary Fig. 1). Retrospective review of the available clinical information for the proband of Family 4, that
was negative for the COL27A1 c.2089G>C (p.Gly697Arg)
variant, showed that the patient only had bilateral hip dislocation and short stature but no apparent clinical manifestations involving her elbows, and no carpal coalitions,
scoliosis, or foot deformities as in the other patients. In
addition, her mother also had unilateral hip dislocation,
suggesting a possible dominant disease trait or common
complex trait of hip dislocation. ES of the proband did not
reveal any additional variants of interest in COL27A1 (data
not shown) and the absence of the founder allele is inconsistent with a pseudodominant inheritance pattern that might
arise from an affected individual marrying a carrier [22].
We also performed allele speciﬁc genotyping of the
c.2089G>C (p.Gly697Arg) variant in suspected Steel syndrome families ascertained since our initial study, including
a duo composed of the unaffected mother and her reportedly
affected 7-year-old son with clinical and radiological ﬁndings of STLS, whom was recently published separately
along with other two STLS patients [23]. The affected
proband (BAB8472) was found to be homozygous for the
STLS variant and his unaffected mother is, as anticipated, a
heterozygous carrier. Separately, an affected 39-year-old
female proband (BAB7802, Table 1) referred for a suspected clinical diagnosis of STLS, presented with short
stature (1.47 m, −2.46 SD) and bilateral congenital hip
dysplasia; joint instability with numerous dislocations
involving the knees, elbows, and toes. There also was a
history of motor delay; hearing loss that developed in the
4th decade of life; and difﬁculty with ambulation requiring
a walker. She has severe scoliosis with lumbar lordosis,
arthritis of the hip, knees, wrists, and spine, and describes
progressive fatigue, joint pain, and disability manifesting
during the last decade. The proband reported a loss of 7.62
cm in height over a 20 year period. Family history is
positive for two similarly affected adult siblings with short
stature, congenital hip and knee dislocations, scoliosis, and
hearing loss (Supplementary Information). The family
(HOU2809) is of Puerto Rican ancestry with no reported
consanguinity and additionally composed of unaffected
parents of normal stature (father 1.63 m [−1.93 SD] and
mother 1.60 m [−0.51 SD]) and two other unaffected siblings of normal height. ES and targeted mutation testing in
all affected siblings conﬁrmed a molecular diagnosis of
STLS due to homozygosity for the c.2089G>C (p.
Gly697Arg) variant in COL27A1 (Fig. 1b). Review of the
ES data for rare variation in genes associated with hearing
loss revealed one heterozygous shared variant in CLCNKA
(NM_004070.3:c.820G>A; p.Asp274Asn). CLCNKA has
been associated with Bartter syndrome type 4b [MIM
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#613090] through digenic inheritance in combination with
CLCNKB variants. However, no additional shared single
nucleotide or copy number variants in CLCNKB were
identiﬁed, and there is no clinical history of salt wasting, a
major clinical feature of Bartter syndrome (MIM #613090),

1247

in the affected siblings. Given the absence of digenic
inheritance of CLCNKA and CLCNKB variants, and the
incomplete phenotypic overlap in this family, the observed
hearing loss in the affected siblings cannot be attributed to
the identiﬁed CLCNKA variant alone.
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Fig. 1 Spectrum of pathogenic allelic variation in COL27A1 and
novel variants identiﬁed in unrelated Turkish kindreds. a Domain
structure of COL27A1 protein and variants identiﬁed to date associated
with human disease phenotypes. Depicted are the Laminin G domain, the
triple-helical domain characteristic of collagen proteins, and the ﬁbrillar
collagen C-term domain. The c.2089G>C (p.Gly697Arg) variant causative of Steel syndrome (STLS) occurs and likely disrupts the triplehelical domain, the c.2683G>A; p.(Gly895Arg) variant identiﬁed in
Turkish patient (BAB5133) also occurs within the triple-helical domain
potentially disrupting the structure of the protein. A novel frameshift
variant c.4976_4980del; p.(Gly1660Aspfs*3) in a second Turkish patient
(BAB8900) and an 11 bp deletion c.63-4_69del; p.(Gly22Serfs*6) in
patient (BAB10793) are predicted to result in loss of function of
COL27A1. b (B1 and B2) Pedigree and Sanger traces of Puerto Rican
family referred for a clinical diagnosis of STLS. As expected affected
individuals carry homozygous G>C change shown in red, resulting in the
c.2089G>C (p.Gly697Arg) STLS variant. Unaffected mother is heterozygous for the variant. c (C1) Pedigree of family HOU2031. Index
patient, BAB5133, is dark ﬁlled square and pointed with a black arrow.
(C2) Segregation of identiﬁed missense variant [COL27A1:c.2683G>A;
p.Gly895Arg] conﬁrmed by Sanger sequencing in the family. Mutation
is shown in red. Parents are heterozygous for the variant and patient is
homozygous. (C3) Pictures of the index patient at different ages: C3.1
and C3.2 were taken at 15 months old showing midfacial hypoplasia,
upturned nostril, short nasal bridge, and rhizomelic shortness. C3.3 and
C3.4 pictures taken at 4 years old showing midfacial hypoplasia,
upturned nostril, short nasal bridge, long philtrum, rhizomelic shortness,
and genu valgum. (C4) X-rays of the patients showing: coxa valga
(C4.1), radial head dislocation (C4.2), patellar dislocation (C4.3), and
long vertebral pedicles (C4.4). d (D1) Pedigree of family HOU3210.
Index patient, BAB8900, is indicated with a black arrow and dark ﬁlled
circle. (D2) Segregation of identiﬁed frameshift variant [COL27A1:
c.4976_4980del; p.(Gly1660Aspfs*3)] conﬁrmed by Sanger sequencing
in the family. The beginning of deletion is marked in red. As expected,
individuals who carry the heterozygous deletion, BAB8901 (mother) and
BAB8902 (father), have peak on peak appearance, while BAB8900 has
normal appearing peaks due to homozygous deletion. (D3) Colored
pictures of index case. D3.1 was taken at 9 years of age showing short
nasal bridge, rhizomelic shortening of upper extremities, scoliotic posture. D3.2 was taken at age 11 showing the facial dysmorphic features
including thick eyebrows, midface hypoplasia, and long philtrum. (D4)
Skeletal survey of the index case showing multiple anomalies including
tall vertebral body as pointed by yellow bracket (D4.1), severe scoliosis
(D4.2), radial head dislocation (D4.3), hip dysplasia pointed by yellow
arrow (D4.4), patellar dislocation (D4.5), and carpal (D4.6) and tarsal
(D4.7) coalitions, merged bones are circled by dashed yellow lines.
e (E1) Pedigree of family HOU3964, index BAB10793 is shown as
black ﬁlled square. (E2) Segregation study of identiﬁed 11 bp deletion
[COL27A1:c.63-4_69del; p.(Gly22Serfs*6)] in the family showing peak
on peak signals in heterozygous parents and normal peaks for the
homozygous deletion patient. (E3) Colored pictures of proband. E3.1 and
E3.2 are pictures of the index patient showing typical dysmorphic features including midface hypoplasia, short nasal bridge, upturned nostril,
long philtrum, rhizomelic shortness, and genu valga. (E4) Skeletal
images of the index patient pointing long vertebral pedicles shown with
yellow bracket (E4.1), glenoid hypoplasia pointed with yellow arrow
(E4.2), femoral bowing shown with yellow line and hip dysplasia
pointed with yellow arrow (E4.3). f Global distribution of pathogenic
alleles identiﬁed to date in COL27A1. In purple the STLS c.2089G>C
(p.Gly697Arg) founder allele identiﬁed in families of Puerto Rican
ancestry. In blue, the three different pathogenic alleles identiﬁed in
homozygosity in unrelated Turkish families reported here. In gray, previously reported disease associated variants in other populations [7–11].
Different disease-causing alleles homozygosed by consanguinity in the
Turkish population and other populations around the world supports the
Clan Genomics hypothesis.
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Molecular characterization of an allelic series at the
COL27A1 locus
Independently, we performed ES and family-based genomic
analyses of two different Turkish families in which the
affected probands had uncharacteristic skeletal dysplasias.
The ﬁrst family (HOU2031) is composed of an affected 4year-old male proband (BAB5133) and his unaffected
consanguineous parents (Table 2, Fig. 1c, and Supplementary Information). Parental consanguinity was elicited by
historical report and further evidenced by a total genomic
absence of heterozygosity (AOH) of 422.948 Mb in the
proband calculated from ES data. The ﬁrst clinical examination for dysmorphic features occurred at age 1 year and
3 months and revealed wooly sparse hair, prominent forehead, short upturned nose, long philtrum, torticollis, rhizomelia of the upper limbs, bowing of femurs, rocker bottom
feet, pes planovalgus, and joint laxity. The proband was
short for age, had mild developmental delay and unilateral
conductive deafness presumed secondary to recurrent
infections. X-rays showed bowing bent femurs, delayed
epiphyseal ossiﬁcation, and hypoplastic clavicles and prominent metaphyseal irregularity. Lumbar kyphosis was also
noted. X-rays of lateral spine and forearms at 5 months of
age revealed tall vertebral bodies, long vertebral pedicles,
and possibly dislocated radial heads.
ES and rare variant family based genomic analyses of
the proband identiﬁed a homozygous variant in exon 19
of COL27A1 [hg19 chr9:g.116999951G>A; COL27A1:
c.2683G>A; p.(Gly895Arg)]. The variant is novel and
absent from our internal databases, nor has it been reported
in any available public database. The variant is predicted to
be likely deleterious or damaging due to high conservation
of the residue and predicted to be function altering
according to Polyphen2 and Mutation Taster. Similar to the
STLS c.2089G>C (p.Gly697Arg) variant, this variant likely
affects the collagen triple-helical domain of the protein
(Fig. 1a). On follow-up, a detailed skeletal examination at 6
years of age did not identify any carpal coalitions.
The second Turkish family (HOU3210) is composed
of an affected female proband (BAB8900, Table 2 and
Fig. 1d), unaffected consanguineous parents and two
reportedly unaffected siblings. The proband had an
uncomplicated prenatal and birth history. Physical examination at age 11 years revealed bilateral hearing loss,
motor developmental delay, limited elbow movement,
scoliosis, bilateral limited hip movement, genu valgum,
patellar dislocation, and pes equinovarus. Skeletal survey
revealed radial head dislocation, carpal, and tarsal
coalitions, clinodactyly, tall vertebral bodies, bilateral hip
dysplasia (right worse than left), and partial knee
dislocation (right worse than left) and pes cavus. ES analysis identiﬁed a homozygous frameshift deletion in exon

No

8 M; 15 F

NA

7 y (0.5–17 y)

COL27A1 Variant(s)

Consanguinity

Gender

Zygosity

Age at evaluation

39/46 (85%)

33/46 (72%)

15/23 (65%)

Pes cavus (35%) Pes cavus (34%)

4/23 (17%)

Carpal coalition

Radial head dislocation

Scoliosis

Foot deformity

Vertebral anomalies

No hyperlaxity

Joint anomalies

Long oval face

Facial features

NA

Other skeletal anomalies Pectus
carinatum/
excavatum
3/23 (13%)

NA

NA

Vertical talus

Acetabular dysplasia

+

+

NA

No hyperlaxity

+

Under ossiﬁed
capital femoral
epiphyses

NA

NA

Decreased elbow NA
extension

NA

NA

−

1/32 (3%)
+

NA
NA

NA

−

NA

NA

Bilateral 5th
ﬁnger
clinodactyly

3/5 (60%)

−

−
1/3 (33%)

2/5 (40%)

1/5 (20%)

2/5 (40%)

5/5 (100%)

5/5 (100%)

1/5 (20%)

Genu Valgum

HMZ
51.6 y (34–74 y)

NA

NA

No
2 M; 3 F

+

+

+

Lumbar lordosis

Coxa vara

Puerto Rican
c.2089G>C;
p.Gly697Arg

3/3 (100%)

1/3 (33%)

3/3 (100%)

3/3 (100%)

3/3 (100%)

14 and 12 y

HMZ

1 M; 2 F

No

c.2089G>C;
p.Gly697Arg

Puerto Rican

GonzagaBelbin et al. [5]
Jauregui et al. [4]

+

Brachydactyly

NA

3/32 (10%)

17/32 (53%)

29/32 (91%)

47/64 (73%)

Digit anomalies

Other skeletal and radiological ﬁndings

20/23 (87%)

Short stature

32/32 (100%)

23/23 (100%)

32/32 (100%)

17.8 y (3.7–50 y)

NA

17 M; 15 F

No

NA

Puerto Rican

Flynn et al. [2]a

Congenital bilateral hip
dislocation

Steel syndrome features

Puerto Rican

NA

Ethnicity

Steel et al. [1]

Table 1 Clinical characteristics of STLS patients homozygous for the p.Gly697Arg variant in COL27A1.

HMZ

3 M; 2 F

No

c.2089G>C;
p.Gly697Arg

Puerto Rican

NA

Pectus
excavatum (2/3)

Decreased elbow
extension; multiple
joint pain

1/3

NA

NA

NA

NA

NA

NA

Metatarsus
adductus (1/3)

3/3 (100%)

2/3 (66%)

NA

2/3 (66%)

3/3 (100%)

NA

NA

NA

NA

NA

NA

NA

+

NA

NA

NA

5/5 (100%)

5/5 (100%)

5/5 (100%)

5/5 (100%)

5/5 (100%)

+

+

NA

+

+

39

HMZ

F

No

c.2089G>C;
p.Gly697Arg

Hispanic

GHS01
(this study)

NA

NA

−

NA

Elbow
deformity;
Multiple
joint pain

NA

NA

NA

NA

NA

NA

+

Decreased elbow
extension; patellar, elbow,
knee, and toe
dislocations; joint pain

+bilateral

−

+

NA

+

Brachydactyly

+

Pes planus; Displacement +
of cuneiform

3/3 (100%)

3/3 (100%)

NA

3/3 (100%)

3/3 (100%)

33, 39 and 48 y

HMZ

1 M; 2 F

No

c.2089G>C;
p.Gly697Arg

Puerto Rican

STLS patientsb HOU2809
(this study)
(this study)

2 months, 7 and 14 y NA

HMZ

2 M; 1 F

No

c.2089G>C;
p.Gly697Arg

Puerto Rican

Amlie-Wolf et al.
[23]
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+

NA

NA

Frontal bossing

Arched/thick eyebrows

NA
NA
NA
NA
NA

+

NA

NA

Ears

Other dysmorphic
features

+
−
−
−

NA
+

+
Microcephaly and
failure to thrive (1
pt); Osteopenia (1
pt)

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

GHS01
(this study)

Arthritis and joint
arthralgia, myopia

+

3/3; Bilateral dx >30 y

Failure of total
hip arthroplasty

+

Bilateral
dx >30 y

Normal development and NA
intelligence

NA

NA

NA

NA

NA

+

+

NA

NA

NA

NA

STLS patientsb HOU2809
(this study)
(this study)

This study reports the molecular ﬁndings of 5 of the original STS patients reported by Steel et al. [1] and reviewed by Flynn et al. [2].

The report by Flynn et al. [2] includes 18 of the 23 patients originally reported by Steel et al. [1] plus additional 14 patients.

b

a

M male, F female, y year old, HMZ homozygous, CMPD HTZ compound heterozygous, NA not available/assessed.

Some individuals
with arthritis,
osteoporosis or
osteopenia

NA

NA

−

NA

NA

NA

Walking difﬁculties

Other clinical features

NA

−

−

−

−

NA

Hearing loss

NA

NA

Normal
development and
intelligence (2/3)

NA

Small, posteriorly
rotated ears

+

NA

NA

+

+

+

+

+

NA

Amlie-Wolf et al.
[23]

Normal developmental Normal
NA
milestones (100%)
development and
intelligence

NA

Developmental Delay

Additional clinical features

NA

NA

Long philtrum

High-arched palate

NA

NA

Anteverted nares

NA

+

+

NA

Short and broad
nasal bridge

NA
NA

+
−

+

NA

NA

Midface hypoplasia

Hypertelorism

+

NA
NA

+
−

NA

NA

+

+

NA

Prominent forehead

GonzagaBelbin et al. [5]
Jauregui et al. [4]

Steel et al. [1]

Flynn et al. [2]a

Table 1 (continued)
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HMZ
3y

HMZ

–

Gender

Zygosity

Age at evaluation

+

+
Pes equinovarus
NA

NA
−
+

85%

~50%

~65%

Scoliosis

Foot deformity

Vertebral anomalies

NA

+
+;
+
femoral bowing
NA
+
NA

+

+

NA

+

+

Coxa vara

Genu valgum

Vertical talus

Acetabular dysplasia

Joint anomalies

NA

+

Bilateral

+

+

NA

+

Lumbar lordosis

NA

NA

NA

NA

NA

NA

Bilateral 5th ﬁnger NA
clinodactyly;
Partial syndactyly
of ﬁngers and toes

None noted

+

Digit anomalies

Other skeletal and radiological ﬁndings

NA

+

+

Radial head dislocation 65%
+

+
NA

+

5y

HMZ

+

5y

CMPD HTZ

Yes
M

+

77%

Carpal coalition

No
F

+

NA

95%

Short stature

Saudi

Unspeciﬁed

Thuresson et al.
[10]

NA

NA

NA

NA

+

NA

NA

+

Pes cavus

+

NA

NA

+

+

10 y

HMZ

F

Yes

c.521_528del;
c.4261–1G>A c.2710G>A;
p.Cys174Serfs*34|
p.Gly904Arg
c.2119C>T;
p.Arg707*

Indian

Kotabagi et al. [8] Maddirevula
et al. [9]

NA

+

Congenital bilateral hip 100%
dislocation

Steel syndrome features

Yes
F

No

–

Consanguinity

c.2089G>C; c.3556–2A>G
p.Gly697Arg

COL27A1 Variant(s)

Emirati

Puerto Rican

Ethnicity

STLS patients Gariballa et al.
[7]

Table 2 Clinical characteristics of patients with biallelic protein altering variants in COL27A1.

Turkish

BAB5133
(this study)

Yes

+

Hyperlaxity

NA

NA

+
NA

+;
femoral bowing

NA

Kyphosis

5th ﬁnger
clinodactyly

Torticollis

Turkish

BAB10793
(this study)

+

+

+

+

+

11 y

HMZ

F

Yes

NA

NA

+;
femoral bowing

+

+

5th ﬁnger
clinodactyly

+

Limited elbow and NA
hip movement;
patellar dislocation

+

+

+

NA

+

5th ﬁnger
clinodactyly

+

+ (Mild)

−

+

−

+

+

5–21 months

HMZ

M

Yes

c.4976_4980 del; c.63–4_69del;
p.Gly1660Aspfs*3 p.Gly22Serfs*6

Turkish

BAB8900
(this study)

Pes equinovarus; Pes equinovarus;
Pes planovalgus Pes cavus

+

(Suspected)

−

+

+

6y

HMZ

M

NA

+

+

NA

+

+

+

NA

+

+

9y

CMPD HTZ

F

No

c.93del; p.
c.2683G>A;
Phe32Leufs*71|
p.Gly895Arg
c.3075del;
p.Lys1026Argfs*33

Syrian

Pölsler et al. [11]

Functional biology of the Steel syndrome founder allele and evidence for clan genomics derivation of. . .
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NA

+

Frontal bossing

NA

NA

Ears

Other dysmorphic
features

Retrognathia

Conical teeth

Bilateral low
set ears

NA

NA

NA

+

NA

NA

NA

NA

+

+

NA

Pölsler et al. [11]

Mild intellectual
disability.
Homozygous
FRMD4A VUS

NA

+; bilateral

+

NA

NA

NA

NA

NA

NA

+

NA

NA

NA

NA

NA

Wooly
sparse hair

NA

Bilateral
colobomata,
hyperopia and
strabismus

+

+; bilateral

Ventricular
septal defect,
pulmonary
hypertension

+

Unilateral,
conductive

Motor
+
developmental and
speech delay

NA

NA

NA

+

NA

+

+

+

NA

+

+

−

+

+

Delayed
epiphyseal
ossiﬁcation,
hypoplastic
clavicles,
metaphyseal
irregularity

BAB5133
(this study)

NA

+

NA

+

+

NA

+

NA

Rhizomelic
Thoracolumbar
shortening of
kyphosis
upper extremities,
femoral collum
pseudoarthrosis,
sacral dimple

Thuresson et al.
[10]

M male, F female, y year old, HMZ homozygous, CMPD HTZ compound heterozygous, NA not available/assessed.

NA

Inguinal hernia
and
undescended
testicles

+

+

NA

Walking difﬁculties

Other clinical features

+

Bilateral
Severe, bilateral, +
hearing loss sensorineural
of adult onset

Hearing loss

NA

NA

Normal
development
and
intelligence
Normal
Motor
NA
development but developmental and
speech delay
speech delay

NA

Bilateral low
set ears

+

+

+

+

Telecanthus

NA

NA

+

+

+

Developmental Delay

Additional clinical features

NA

+

High-arched palate
NA

+
+

+

+

Anteverted nares

+

+

Short and broad
nasal bridge

Long philtrum

+
NA

+

+

Midface hypoplasia

Hypertelorism

+

NA

+

Arched/thick eyebrows +

NA

+

Prominent forehead

NA

Small and under
ossiﬁed femoral
epiphyses

+
Rhizomelic
shortening of
upper
extremities

Kotabagi et al. [8] Maddirevula
et al. [9]

STLS patients Gariballa et al.
[7]

Long oval face

Facial features

Other skeletal
anomalies

Table 2 (continued)
BAB10793
(this study)

NA

+

+; bilateral

+

NA

NA

NA

+

+

+

NA

+

+

NA

−

+

NA

+

+

+

NA

NA

NA

+

+

+

NA

+

−

NA

+

NA

Rhizomelic
Rhizomelic
shortening of upper shortening of
extremities
upper
extremities

BAB8900
(this study)
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58 [hg19 chr9:g.117068837_117068841del; COL27A1:
c.4976_4980del; p.(Gly1660Aspfs*3)] that is predicted to
result in the introduction of a premature stop codon with
likely degradation of the altered COL27A1 mRNA transcript through NMD [9] (Fig. 1a).
A third family (HOU3210), also from Turkey, includes
a 21-month-old male proband (BAB10793, Table 2 and
Fig. 1e) born to unaffected consanguineous parents. He
was initially evaluated at age 5 months, and classical
clinical features such as scoliosis, hip dislocation, and
short stature prompted a suspected clinical diagnosis of
STLS and subsequent molecular evaluation by Sanger
sequencing of the entire COL27A1 gene to look for
potential protein altering variants. He was found to have a
homozygous 11 bp deletion involving the intron1/exon2
boundary [hg19 chr9:g.116924991_116925001del; c.634_69del; p.(Gly22Serfs*6)] deleting the splice acceptor
site of exon 2 and introducing an early stop codon in the
mRNA transcript that is likely degraded through NMD.
Skeletal survey at 18 months old showed glenoid fossa
hypoplasia, radial head dislocation, tall vertebral bodies,
long vertebral pedicles, left hip dislocation, and dysplasia
as evidenced by an acetabular roof that is irregular and at
an increased angle (coxa vara), bowing of the femurs (right
worse than left). Radiographs of the feet were not available
for review. This proband additionally has developmental
delay and hearing loss.
Of note, the variants identiﬁed in COL27A1 in these
three Turkish individuals with skeletal dysplasia have not
been observed in any publicly available variant databases
nor in ~1100 exomes from Turkish individuals sequenced
as part of the BHCMG initiative. Further, and likely due to
consanguinity in the parents of the probands, these rare
variants map within regions of AOH ranging from 3.68 to
8.83 Mb in length, as delineated from unphased ES variant
data and presumably reﬂecting runs of homozygosity
resulting from IBD in the personal genomes of these individuals (Fig. 2). The rarity of the variants identiﬁed and the
total genome-wide AOH, calculated from WES data, for the
Turkish probands is consistent with a clan genomics IBD
and transmission genetics homozygosity of a recent mutation in the family or clan versus an older founder allele
homozygosed [24] by geographic or population isolation
[25, 26] (Fig. 1f).

Phenotypic characterization of COL27A1 c.2089G>C
(p.Gly697Arg) variant carriers from a large clinical
cohort and haplotype reﬁnement
Through the Geisinger–Regeneron DiscovEHR collaboration that pairs genomic data with EHR information [14], we
were able to identify 28 adult heterozygous carriers of
the c.2089G>C (p.Gly697Arg) variant in COL27A1 and 1
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homozygous female. Twenty-three of these 29 individuals
have self-reported ancestry information of being Hispanic,
consistent with the known genetic background for the STLS
variant, although without further detail available. Review of
the EHR information for the homozygous individual
revealed a clinical presentation consistent with STLS
including history of congenital hip dysplasia, short stature
(1.50 m), scoliosis, radial head subluxation, and foot
abnormalities. She also has diagnoses of tinnitus and
bilateral sensorineural hearing loss ﬁrst recorded at 38 years
of age. Furthermore, her EHR documents a history of surgical interventions and failures for hip arthroplasty accompanied by chronic pain affecting multiple joints (Table 1
and Supplementary Table 1), consistent with previous
reports of untoward surgical outcomes in STLS patients [2].
The sizable number of heterozygous carrier individuals
allowed us to further explore the possible contribution of
the carrier status to common skeletal and joint phenotypes.
While not statistically signiﬁcant, manual exploration of the
EHR data for these individuals revealed some recurrent
clinical diagnoses of cervicalgia (ICD9 723.1), arthropathy
(ICD9 716.9), osteoarthrosis (ICD9 715.00), and pain in
back, limbs, and joints across the 28 heterozygous STLS
variant carriers (Supplementary Table 1). In addition,
whole-genome IBD segment mapping across carriers of the
c.2089G>C (p.Gly697Arg) variant showed that all carriers
share the region in which the variant is embedded IBD.
Through this analysis we were also able to further reﬁne the
region containing this founder variant to a 2.682 Mb common haplotype (Supplementary Fig. 2).

In vivo mouse modeling of the Steel syndrome
c.2089G>C (p.Gly697Arg) variant
To garner functional evidence for pathogenicity, and better
understand the pathophysiological effects of the identiﬁed
c.2089G>C (p.Gly697Arg) variant and disease trait biology
in individuals with STLS, we engineered a KI mouse
model. The human COL27A1 and mouse Col27a1 orthologous genes are 84% identical at the nucleotide level and
the encoded proteins are 90% identical and 94% similar at
the amino acid level. To model the human c.2089G>C
(p.Gly697Arg) variant, the equivalent G>C mutation was
introduced in the murine Col27a1 gene resulting in a
p.Gly682Arg substitution (orthologous to the human variant) in the mouse (Supplementary Fig. 3).
Initial generation of this engineered mouse line was
performed on a C57BL/6N (Black 6) genetic background,
however multiple rounds of breeding failed to deliver any
surviving homozygous animals at time of genotyping.
Consequently, heterozygous KI mice were bred to 129S6/
SvEvTac wild-type (WT) mice to outcross and generate a
mixed background line. Matings of heterozygous animals
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A

B

C
c.2089G>C;
p.Gly697Arg

p24.1 p23

BAB
9010
GCC T CGGC T

G C C T GC G G C T

Variant/total Reads Ratio

BAB
9002
BAB
7802
BAB9015

HOU2809

p21.3

p21.1

11.2

11

q12

q13

q21.13

q31.1

31.3

q33.1

q33.3

BAB7802
GCC TCGGC T

2

q32

Chr9

GCC TCGGC T

1
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
1.0e+08

1.1e+08

1.2e+08

1.3e+08

1.4e+08

1.1e+08

1.2e+08

1.3e+08

1.4e+08

1.1e+08
1.2e+08
Genomic Coordinates

1.3e+08

1.4e+08

c.2683G>A;
p.Gly895Arg

BAB
5133
BAB5136 BAB5135

HOU2031

AG TCA G A G A

A G T C GA G A G A

A G T C GA G A G A

Variant/total Reads Ratio

BAB5133
1
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
1.0e+08

c.4976_4980del;
p.Gly1660Aspfs*3

2
BAB
8900
BAB8902 BAB8901

HOU3210

A GGG AGATC T T T A

AGGGA GAA C ATA

AGGGA GAA C ATA

Variant/total Reads Ratio

BAB8900
1
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
1.0e+08

Fig. 2 Runs of homozygosity in pedigrees segregating pathogenic
variants in COL27A1. a The pedigree of the families with family ID
(HOU #) above and individual ID # below in each individual. Affected
individuals are shown as black-ﬁlled symbols. b Segregation study of
the COL27A1 variants in individuals from each of the different

pedigrees. c (Top) Ideogram of chromosome 9. (Bottom) Zoomed-in
views (dashed line) of B-allelic frequency plots encompassing the
COL27A1 region. The coordinates of COL27A1 variants are indicated
by vertical red lines embedded within an AOH block shown as gray
regions.

with this hybrid genetic background were able to produce
viable, albeit only a few, homozygous KI animals (N = 7)
that survived past weaning age. Genotyping of three litters
at postnatal day 1 (N = 23 pups) revealed expected Mendelian ratios for the different genotypes: 21.7% WT (n = 5),
52.2% heterozygous (Col27a1G682R/+; n = 12), and 26.1%
homozygous (Col27a1G682R/G682R; n = 6) KI mice. However, homozygous KI mice displayed severe lethality before
P7, with only a few pups surviving post weaning age.
Phenotyping of homozygous KI embryos at E18.5 showed
abnormal skull shape with a shortened snout, but no

signiﬁcant differences in embryo size or length at this stage
(Supplementary Fig. 4). This was further quantiﬁed as the
ratio of head length to head height, showing that snouts of
homozygous KI embryos were signiﬁcantly shorter (P =
7.54 × 10−7) than those of heterozygous KI or WT embryos
(Fig. 3). In addition, homozygous KI embryos had abnormal lungs with poorly developed airspaces and thickened
mesenchyme (data not shown).
Seven homozygous KI mice, from different litters,
survived past weaning age and were subjected to further
evaluation for gross phenotypic and skeletal changes. We

Functional biology of the Steel syndrome founder allele and evidence for clan genomics derivation of. . .
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Fig. 3 Abnormal skull shape and reduced snout length in
homozygous (G682R) KI embryos. Phenotyping of Col27a1 wildtype (WT), heterozygous Col27a1G682R/+, and homozygous
Col27a1G682R/G682R KI embryos at E18.5 with microcomputed tomography imaging. Skull shape in the homozygous mutant mice is
rounder with a signiﬁcantly shorter snout as compared with wild-type

and heterozygous KI embryos. Abnormal skull shape and snout length
were quantiﬁed as the ratio between head length (L1) over head height
(L2), difference between the distribution of head ratios was evaluated
between wild-type and heterozygous KI embryos which appear normal
and homozygous KI embryos.

performed computerized tomography (µCT) whole-body
scans of heterozygous (Col27a1G682R/+) and homozygous
(Col27a1G682R/G682R) KI mice and WT littermates to evaluate for gross skeletal abnormalities and reduced body
length as a surrogate for the short stature phenotype
observed in the human subjects [27]. We measured the
snout to base of the tail (at caudal vertebra 4, CA4) distance
to evaluate differences in body length among the heterozygous, homozygous, and WT mice. Homozygous mutant
mice were evidently smaller compared with WT or heterozygous littermates (Fig. 4a). Total body length was
markedly decreased (Fig. 4b, f) and all the long bones were

shorter. Homozygous KI mice also showed distinct craniofacial abnormalities including shorter snout and slightly
rounded dome shaped skull, also observed in the embryonic
stage (Fig. 3 and Supplementary Fig. 4). Analysis of the
vertebral column demonstrated severe thoracic kyphosis at
3 weeks of age in all the homozygous KI mice evaluated,
leading to an acute angle between the skull and cervical
vertebrae resulting in inward curvature of the rib cage.
Homozygous KI mice also developed varus deformity
observed by µCT as a structural deformity of the hind limbs
with tibial tuberosity shifting inwards resulting in the tibia
being twisted towards the midline and causing the digits to
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Fig. 4 Phenotyping of Col27a1 knockin (KI) mutant mice.
a Homozygous Col27a1G682R/G682R KI mice displayed signiﬁcant
dwarﬁsm, heterozygous Col27a1G682R/+ KI mice were phenotypically
normal and indistinguishable from wild-type littermates at 3 weeks of
age. b–e Longitudinal monitoring of length, body weight, and skeletal
parameters: bone mineral content (BMC) and bone mineral density
(BMD) in homozygous and heterozygous KI mice versus wild-type

littermates. Homozygous (Col27a1G682R/G682R) KI mice are smaller in
length (b), display decreased body weight (c), and BMC (e) consistent
with their smaller body size, but no difference in normalized BMD (d).
f Dorsal and lateral µCt images of wild type (F1), heterozygous KI
(F2), and homozygous KI (F3). Heterozygous KI mice do not appear
different from wild-type littermates, whereas homozygous KI mice are
smaller in size, display kyphosis, a shorter snout and rounded skull.

point inwards when mice are in the supine position (Supplementary Fig. 5). About two thirds of the heterozygous
mice evaluated also had a milder presentation of a varus
deformity (Supplementary Fig. 5). Analysis of skeletal
parameters revealed that homozygous mutant mice displayed lower BMC as compared with heterozygous KI and
WT mice (Fig. 4d, e) consistent with their smaller size and
overall reduced whole-body bone volume. Homozygous

mice were half the body weight compared with WT littermates, and their growth curve remained lower throughout
the monitoring period of 6 months compared with WT and
heterozygous littermates. Heterozygous mice were viable
and did not display any other gross skeletal abnormalities
beyond the above mentioned mild varus deformity in some;
skeletal parameters were indistinguishable from WT littermates. We monitored homozygous and heterozygous KI
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mice over a 6 month period; aging did not result in development of other gross or detectable skeletal abnormalities at
a later age in heterozygous mice.

Histological analyses of Steel syndrome mouse
model and growth plate defects
To further explore the Steel syndrome founder allele for
potential insights into skeletal biology, and the potential
mechanism(s) by which defects in COL27A1 result in
osteochondrodysplasia, we collected long bones (femurs
and tibias) from heterozygous (Col27a1G682R/+) and
homozygous (Col27a1G682R/G682R) KI mice, and WT littermates at P1 to perform histological analyses. Stained sections of femoral and tibial growth plates of homozygous KI
mice showed loss of the normal architecture of the proliferative zone with absence and disorganization of columnar chondrocytes (Fig. 5a–c and k–m, Supplementary
Figs. 6 and 7). We observed a qualitative increase in PCNApositive cells in the proliferative zone of the heterozygous
and homozygous KI mice as compared with WT littermates
(Supplementary Fig. 6). Histochemical comparison of
Safranin-O and von-Kossa stains displayed no overt differences in proteoglycan accumulation and mineralization
in homozygous KI mice versus heterozygous KI and WT
mice (Fig. 5d–j and n–s). Similarly, immunohistochemical
analysis demonstrated no overt differences in Collagen II
and Collagen X staining in the growth plate region (Supplementary Fig. 7). Interestingly, while the length and gross
morphology of the long bones in heterozygous KI mice is
not different from WT littermates, histological analyses of
the growth plates in these mice revealed an intermediate
phenotype, where the length of the proliferative zone of the
growth plate is maintained but some disorganization in the
columnar arrangement of chondrocytes can be observed
(Fig. 5, B1, B2, L1, L2, and Supplementary Figs. 6 and 7).

In vitro functional characterization of disease
associated missense variants in COL27A1
To elucidate the potential molecular mechanism underlying
the disease trait and clinically observed phenotypes due to
point mutations in COL27A1, we evaluated whether the
two observed glycine substitutions (p.Gly697Arg and
p.Gly895Arg) within the triple-helical domain of COL27A1
interfered with the biosynthesis of the protein in vitro
(Supplementary Methods). To this end, we overexpressed
GFP-tagged WT, G697R, or G895R human COL27A1
constructs in W20 or ATDC5 cells, a mouse chondrogenic
cell line that serves as an appropriate in vitro model for
chondrocyte differentiation [28], and evaluated ER retention
by co-localizing with an ER-retained ER-Crimson ﬂuorophore. Our experiments showed modest ER-retention of

1257

the mutant proteins as compared with the WT in both W20
and ATDC5 cells (Supplementary Fig. 8A, B), suggesting
that potential disruption of the triple helical collagen
domain of COL27A1 may lead to abnormal folding and
secondary structure. However, we did not speciﬁcally test
for ER-stress or upregulation of the unfolded protein
response. We tested for defects in chondrogenic differentiation of ATDC5 cells in vitro when overexpressing the
mutant constructs versus WT. We used alcian blue staining
to visualize proteoglycan accumulation at different multiplicity of infection (MOIs) (10, 20, 50, and 100) for the
three constructs; however, we did not observe any major or
signiﬁcant differences between the mutations and WT
COL27A1 overexpressing cells (Supplementary Fig. 8C).
It is possible that the observed ER-retention is a result of
the supra-physiological levels of the overexpressed mutated
proteins within the cell as chondrogenic differentiation of
ATDC5 overexpressing G697R or G895R mutant proteins
was unremarkable as compared with WT. In order to exclude
any potential artifacts due to overexpression, we isolated
primary chondrocytes from postnatal day 1 (P1) heterozygous
(Col27a1G682R/+) and homozygous (Col27a1G682R/G682R) KI
mice and WT littermates. After 2 weeks in culture, we performed alcian blue staining to test for chondrogenic defects
among the different genotypes. Consistent with our previous
observation in ATDC5 cells, we did not observe signiﬁcant
differences in chondrogenesis between genotypes as evaluated by proteoglycan alcian blue staining (Supplementary
Fig. 9). These experiments led us to conclude that Col27a1
mutant chondrocytes are able to differentiate and secrete
collagen into the extracellular matrix (ECM) and that the
mechanism of disease in STLS and related osteochondrodysplasias is likely not cell-autonomous.

Discussion
Fibrillar collagens are one of the most well-described,
abundant, and relevant protein families that form major
structural components of extracellular matrices in vertebrates. Collagen XXVII, i.e. COL27A1 the product of the
human and murine COL27A1/Col27A1 gene, is a type C
ﬁbrillary collagen that is developmentally regulated and
expressed in a variety of tissues including the developing
dermis, eye, otic capsule, bronchial and lung epithelium,
and major arteries in the heart during early embryonic
development (mouse E14.5); however at later stages in
development and throughout adulthood it is most prominently and exclusively expressed in cartilage [29, 30]. The
protein has been identiﬁed in primary ossiﬁcation centers, in
the proliferative chondrocytes of the epiphyseal growth
plate, and in the pericellular matrix surrounding the
hypertrophic chondrocytes at the transition zone from
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Fig. 5 Histological analyses of long bones from Col27a1 G682R KI
mice. a–j The growth plate of the developing femur of wild-type, heterozygous Col27a1G682R/+, and homozygous Col27a1G682R/G682R KI mice
at post-natal day 1 stained with hematoxylin and eosin (A1–C1 and
A2–C2 at higher magniﬁcation), safranin-O (D1–F1 and D2–F2 at
higher magniﬁcation) and von Kossa (G1–J1 and G2–J2 at higher
magniﬁcation). k–s The growth plate of the developing tibia of wildtype, heterozygous Col27a1G682R/+, and homozygous Col27a1G682R/G682R
KI mice at post-natal day 1 stained with hematoxylin and eosin (K1–M1
and K2–M2 at higher magniﬁcation), safranin-O (N1–P1 and N2–P2 at
higher magniﬁcation) and von Kossa (Q1–S1 and Q2–S2 at higher
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magniﬁcation). Homozygous Col27a1G682R/G682R KI mice displayed
chondrodysplasia with reduced and disorganized proliferative zone and
complete absence of columnar chondrocytes as compared with wild-type
and heterozygous KI littermates (c, f, j, m, p, s). Although the length and
overall structure of the growth plate is preserved in heterozygous KI mice
as compared with wild-type littermates, some disorganization of the
columnar chondrocytes can be observed (b, e, l, o) Histochemical
comparison of Safranin-O and von-Kossa stains displayed no overt
differences in proteoglycan accumulation and mineralization respectively
between genotypes.

Functional biology of the Steel syndrome founder allele and evidence for clan genomics derivation of. . .

cartilage to bone [29–33]. It has been proposed from a
developmental biology standpoint that this uncharacteristic
collagen plays an important role in the cartilage modeling
phase of endochondral bone formation where cartilage
mineralization and apoptosis of hypertrophic chondrocytes
occurs with invasion of blood vessels and osteogenic cells,
deposition of collagen I and bone formation, therefore
playing an important role in skeletogenesis [29].
We previously reported the association of a rare
COL27A1 missense variant, c.2089G>C (p.Gly697Arg),
causing Steel syndrome when in homozygosis in three
members of a single family; female/male sibs and a female
cousin [4]. Due to the absence of reported consanguinity,
which was further veriﬁed genetically by the lack of sharing
of large segments of homozygosity beyond the region
around the COL27A1 gene delineating a common haplotype
harboring the c.2089G>C (p.Gly697Arg) variant, at the
time we proposed that this variant was the molecular cause
of the disease and that it was likely a founder allele in
individuals of Puerto Rican ancestry. Since then, we and
others [5, 23] have conﬁrmed that homozygosity for this
missense variant is indeed the molecular defect that causes
the skeletal abnormalities observed in STLS.
In this report, we now show that ﬁve of the original
STLS patients reported by Steel et al. [1] are homozygous
for this same c.2089G>C (p.Gly697Arg) variant and that it
segregates in these Puerto Rican families according to
Mendelian expectations for an AR disease trait. In addition,
we report ﬁve more individuals, including four adults, of
Puerto Rican descent and with clinical features consistent
with STLS. As expected, these individuals were also found
to be homozygous for the STLS variant. In aggregate, a
total of 47 patients have been described, including the ones
documented in this report, with clinical ﬁndings corresponding to “The Puerto Rican syndrome” that Dr Steel
reported 50 years ago. Of these, 20 have been molecularly
conﬁrmed and reported to be homozygous for the
c.2089G>C (p.Gly697Arg) variant in COL27A1, all of
Puerto Rican ancestry, conﬁrming our founder allele
hypothesis for this disorder [4]. The reported cases also
document the speciﬁcity of the genotype–phenotype association consistent with a relatively uniform clinical phenotype characterized primarily by bilateral congenital hip
dysplasia (100%), short stature (95%), scoliosis (85%),
carpal coalitions (77%), radial head dislocations (65%), foot
deformities, and vertebral anomalies (~50–65%) (Tables 1
and 2).
We now also report three unrelated probands from Turkey
with homozygous novel pathogenic variants (c.2683G>A:p.
(Gly895Arg), c.4976_4980delGAGGA:p.(Gly1660Aspfs*3),
and c.63-4_69del:p.(Gly22Serfs*6)]) in COL27A1. These
three individuals, in addition to recent case reports of unrelated patients with skeletal dysplasia within the spectrum of
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STLS, were found to have biallelic rare protein altering variants in COL27A1 consistent with an AR disease trait [7–11]
(Fig. 1f). These ﬁndings expand on the phenotypic and variation spectrum of function altering alleles in this gene
enabling the characterization of an allelic series (Table 2 and
Fig. 1). Given the phenotypic overlap but increased severity
and additional features not observed or reported to date in the
majority of the Puerto Rican STLS patients, such as congenital or early onset hearing loss, speech and developmental
delay, and novel radiographic features including tall vertebral
bodies, long vertebral pedicles, and shallow glenoid fossae
(Fig. 1), we propose these to represent an allelic series of
COL27opathies with potentially a broader phenotype spectrum due to biallelic function altering variants in COL27A1
and allowing a more complete clinical synopsis of this locus.
In contrast to the Puerto Rican founder allele for STLS, the
disease associated alleles identiﬁed in the Turkish population
along with the reported protein altering variants in non-Puerto
Rican cases were all distinct variants. This observation is
more consistent with a Clan Genomics hypothesis [12] of
recently arisen rare alleles that are more likely to come
together due to IBD homozygosity driven by consanguinity
rather than genetic drift due to population bottlenecks and
founder mutational events. The high percentage of genomewide AOH due to recent IBD homozygosity observed in the
Turkish subjects is also consistent with this interpretation.
Based on the disease-causing variation spectrum
observed in humans, it appears that some of the clinical
variability among patients with different variants may be
due to the functional effect of the variant and the extent of
perturbation to the translated protein (Fig. 1a). The identiﬁed protein altering amino acid substitutions (p.Gly697Arg,
p.Gly895Arg, and p.Gly904Arg) affect the triple helical
collagen domain of COL27A1. Interestingly, similar
mutations in other collagen types may act as dominant
alleles through dominant negative or antimorphic effects.
Missense variants affecting this domain in COL27A1 are
indeed function altering as demonstrated by STLS and the
Turkish case (BAB5133) reported here, but the severity of
the phenotype might be dependent on the location of the
alteration within the triple-helical domain. Our observations
are consistent with previous experiments from Plumb et al.
[29] where no signiﬁcant engorgement of the ER was
observed in chondrocytes of an in-frame deletion mutant
mouse model, suggesting that protein misfolding and ER
retention [34, 35] were unlikely to play a signiﬁcant role in
the pathology associated with abnormal COL27A1. Furthermore, a different Glycine substitution (p.Gly1516Cys)
towards the end of the triple-helical domain of
COL27A1 showed little phenotypic effect in this same
study, with some disordering of the proliferative zone of
growth plates in homozygous animals [29]. In aggregate,
these data support the hypothesis that members of the type
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C clade of collagens, of which COL27A1 is a member of
along with COL24A1, may be more tolerant, in terms of
folding and secretion, to disruptions of the Gly-X-Y motif
in their triple-helical domain [29–31]. In addition, collagen
XXVII homotrimerizes into thin ﬁbrils in the ECM independently from the thicker ﬁbrils formed by classical (type
A and B) ﬁbrillar collagens possibly allowing to better
accommodate the mutant collagen trimers [30, 32]. These
observations further support the observed recessive inheritance of COL27opathies associated pathogenic alleles as
compared with the usual dominant inheritance pattern
observed for mutations in other classical collagens and the
hypothesis that the phenotypic effects of mutations in the
triple-helical domain may vary depending on the location
within this.
The two additional variants reported here are predicted to
introduce frameshift or splice changes that result in the
introduction of early termination codons that lead to nonsense mediated processing and clearance of the mutant
transcripts, effectively resulting in loss-of-function (LoF)
alleles with consequent loss of the COL27A1 protein. These
two Turkish probands, in addition to the cases reported by
Kotabagi et al. [8] and Pölsler et al. [11] are interesting as
they reveal distinctions in the role and importance of collagen XXVII in human versus other mammalian skeletal
systems. A previously reported mouse model of Col27a1
deﬁciency exhibited severe skeletal abnormalities with
chondrodysplasia and perinatal death due to lung defects
[29]. In contrast to the previously reported mouse models of
Col27a1 mutation that aimed to assess function of this
collagen gene without a human phenotype reference, our
engineered mouse model contains the orthologous variant
equivalent to the most prevalent function altering variant
and human disorder associated with this gene. Our STLS KI
animal model (Col27a1G682R/G682R) recapitulates the short
stature and some of the skeletal abnormalities observed in
the human subjects, however most homozygous KI mice die
perinatally, presumably due to respiratory insufﬁciency
consistent with previous Col27a1 mouse models [29].
Complete absence and hypomorphic alleles in the mouse
Col27a1 gene result in neonatal lethality in addition to
severe skeletal abnormalities; however markedly reduced
and apparent absence of COL27A1 protein in humans
appears to be viable albeit with the reported skeletal
abnormalities in the spectrum of STLS and related
COL27opathies. Interestingly, STLS patients do not appear
to have respiratory problems or lung abnormalities.
Based on our in vitro experiments and observations in
our STLS in vivo mouse model, it appears that disease
associated alterations in COL27A1 do not prevent chondrocytes from differentiating properly. However abnormal
or absent collagen XXVII protein in the ECM results in
collapse of the proliferative zone and disorganization of the
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cartilaginous zones of the growth plate preventing normal
endochondral bone growth possibly through impaired
interactions with other ECM proteins or matrix-sequestered
ligands. Our observations further support the model of
collagen XXVII as an important scaffold for cartilage
mineralization and population of other cell types such as
endothelial and osteogenic cells during skeletal development. Which ligands or ECM factors are being altered by
the absence or disruption of collagen XXVII remain a
subject of future research; however, our STLS model provides a biologically relevant platform to study these further
mechanistic questions regarding COL27opathies with direct
human biology translation.
Mouse Col27a1 was found to be expressed in the cartilaginous structures associated with inner ear development and
cochlear epithelium [32]. This observation may be of relevance considering the associated hearing loss phenotypes
observed in individuals with severe and LoF variants in
COL27A1. Interestingly, in family HOU2809 composed of
three affected siblings with STLS but molecularly diagnosed
and clinically evaluated as adults (ages 33, 39, and 48 years),
all three affected individuals presented with bilateral hearing
loss with onset after 30 years of age. Similarly, patient
GHS01 identiﬁed in the DiscovEHR cohort also developed
bilateral sensorineural hearing loss at 38 years of age. While
hearing loss had not been reported in individuals with STLS,
most of the reported patients are children and therefore it is
plausible that in Puerto Rican STLS patients due to homozygosity for the missense c.2089G>C (p.Gly697Arg) variant,
hearing loss may appear later in life versus early-onset hearing
loss observed in individuals with more severe variants in
COL27A1. Our data on the clinical characterization of adult
STLS patients supports this conclusion.
Belbin et al. suggested that the Puerto Rican c.2089G>C
(p.Gly697Arg) Steel syndrome variant has phenotypic
consequences in both heterozygous and homozygous individuals [5]. The authors conﬁrmed a clinical diagnosis
based on EHR diagnostic codes consistent with STLS for
only the ﬁve identiﬁed homozygous individuals in their
Puerto Rican cohort (N = 115). However as reported,
phenome-wide association analyses of ICD-9 medical billing codes in the EHR of c.2089G>C (p.Gly697Arg) heterozygous carrier individuals failed to identify signiﬁcantly
associated phenotypes, except for one association with
vertebral osteomyelitis driven by three heterozygous individuals. As stated by the authors, manual examination of
EHR data for a subset of heterozygous carriers (N = 34),
using the same clinical criteria that was used for evaluation
of the ﬁve homozygous individuals, found no evidence of
short stature or congenital hip dislocation consistent with
the major observed phenotypes in STLS. Through this
manual examination, the authors observed enrichment of
joint and spine degradation diagnosis codes in the EHR
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data, including moderate-to-severe spinal degeneration and
cervical stenosis and increased rates, albeit not statistically
signiﬁcant, of scoliosis, arthritis, and lumbar spine degradation in the evaluated c.2089G>C (p.Gly697Arg) heterozygous carriers.
Similar interrogation of the EHR information of 28 heterozygous carriers of the STLS c.2089G>C (p.Gly697Arg)
variant in the DiscovEHR cohort showed occurrences of
diagnosis codes for degenerative joint disease and joint
pain, and reported pain in the neck, back and limbs, and
some instances of scoliosis and osteoarthritis. However,
none of these were statistically signiﬁcant or consistent
across all heterozygous carriers of the STLS variant. Our
observations, along with those reported by Belbin et al. are
in line with previous observations of subclinical phenotypes in heterozygous carriers for recessive disorders and
late onset of related disease with milder presentations due
to a sensitized genetic background and life-long exposures
in heterozygotes [36, 37]. Interestingly, initial ﬁndings
from a Chinese cohort of subjects with scoliosis have
identiﬁed enrichment for heterozygous deleterious rare
variants in COL27A1 (unpublished data). In addition, we
observed mild varus deformity and histological differences
in the growth plate of heterozygous KI mice for our STLS
model with moderate disorganization of the proliferative
zone and the columnar arrangement of chondrocytes.
Despite this, the length of the growth plate and overall size
and gross morphology of heterozygote KI animals was
comparable with WT mice. These observations strongly
suggest that whilst the vertical growth is unaffected, the
overall skeletal structure in individuals heterozygous for
the c.2089G>C (p.Gly697Arg) variant may be sensitized
and more prone to degeneration with age and environmental insults and exposures. Altogether, these observations might be more consistent with the COL27A1 locus
contributing to complex osteopathological traits in sensitized heterozygous individuals rather than reﬂecting an
autosomal dominant disease trait.
Of note, the majority of patients with STLS and associated osteochondrodysplasias, COL27opathies, are children. Few adults have been well-phenotyped and followedup in their clinical progression with the disease, therefore
worsening of some of the phenotypes such as vertebral
compression, scoliosis, and hearing loss may potentially
appear with age. This age-dependent penetrance of some
clinical phenotypes is illustrated by the three adult STLS
individuals from pedigree HOU2809 and individual GHS01
that we report herein who developed bilateral hearing loss
of adult onset, and progressive pain and walking difﬁculties.
Similarly, COL27A1 pathogenic variants may confer complex trait susceptibility to scoliosis, vertebral and joint
degeneration, and hearing loss as homozygous and heterozygous carriers age and given additional environmental
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factors such as lifestyle including weight and exercise
routines or noise exposures.
We have demonstrated apodictically that Steel syndrome is an AR disorder clinically characterized by congenital bilateral hip dislocation, short stature, scoliosis,
radial head dislocation, carpal coalitions, and foot deformities; and molecularly deﬁned by homozygosity for
the c.2089G>C (p.Gly697Arg) variant in COL27A1. The
reported allelic series in COL27A1 provides further
insights into disease biology and genetic contributions to
clinical phenotypes in these COL27opathies. Our in vivo
model offers additional evidence for the role of collagen
XXVII as an important element of ECM composition and
growth plate organization for endochondral bone formation during vertebrate skeletogenesis.
It has been estimated that the c.2089G>C (p.Gly697Arg)
variant exists at a minor allele frequency of 1.9% in the
Puerto Rican population [5]. This allele frequency has
strong implications for prevalence estimates of Steel syndrome but furthermore for the accurate diagnosis and
appropriate orthopedic management of these individuals.
Retrospective evaluation of STLS patients concluded that
the hip dislocation is refractory to surgery and that instead
of improving quality of life, surgical intervention is largely
contraindicated for these patients as chronic pain and hip
subluxation with acetabular dysplasia are major iatrogenic
outcomes of such surgical intervention [2]. Implementation
of molecular genetics for the accurate diagnosis of patients
with rare diseases such as STLS or in newborn screen
paradigms for populations at higher risk can prevent
unnecessary treatment interventions that could potentially
lead to life-long distress and disability.
Steel syndrome and associated COL27opathies due to
function altering variants in the gene COL27A1 demonstrate how rare recessive variants can come together and
account for disease burden in speciﬁc populations by
autozygosity either through genetic drift of founder alleles
in culturally [25, 26] or geographically isolated populations such as in Puerto Rico, or consistent with the Clan
Genomics hypothesis [12], through rapid intergenerational
IBD homozygosity due to increased consanguinity of
parents or “clan members” of affected probands. In addition, the observation that some of these rare variants can
contribute in heterozygosity [36] or in combination with
common polymorphisms [38] to more common complex
disorders or to late-onset related clinical presentations [37]
due to life-long exposures in individuals with a sensitized
genetic background, gene–environment interactions, further supports the importance of recent rare variation arising in the “clan” as an important contributor to disease
susceptibility, versus common variation across multiple
populations, and the continuum that connects rare and
common diseases.
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